Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma
Rachel Tanos(Children's Healthcare of Atlanta), Kelly C. Goldsmith(Children's Healthcare of Atlanta)
Cited by 38
Related Papers
Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma
|Cell Reports Medicine|2023|16